PLASMA CARNITINE AND LIPID-LOWERING DRUGS

被引：5
|
作者：
NESTRUCK, AC [1 ]
PANDE, SV [1 ]
DAVIGNON, J [1 ]
机构：
[1] CLIN RES INST MONTREAL, DEPT INTERMEDIARY METAB, MONTREAL H2W 1R7, QUEBEC, CANADA
来源：
ATHEROSCLEROSIS | 1985年 / 55卷 / 03期
关键词：
D O I：
10.1016/0021-9150(85)90112-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：353 / 356
页数：4
相关论文
共 50 条
  • [21] INDICATIONS FOR LIPID-LOWERING DRUGS
    DAVIGNON, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S3 - S10
  • [22] Lipid-Lowering Drugs and Cataract
    Bezin, Julien
    Mansiaux, Yohann
    Pariente, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 555 - 555
  • [23] Lipid-lowering drugs and homocysteine
    de Lorgeril, M
    Salen, P
    Paillard, F
    Lacan, P
    Richard, G
    LANCET, 1999, 353 (9148): : 209 - 210
  • [24] AN OVERVIEW OF LIPID-LOWERING DRUGS
    ILLINGWORTH, DR
    DRUGS, 1988, 36 : 63 - 71
  • [25] Lipid-lowering drugs and mortality
    Corrigan, F
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 289 - 289
  • [26] Semaglutide, lipid-lowering drugs, and NAFLD
    Katsiki, Niki
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 329 - +
  • [27] LIPID-LOWERING DRUGS, HYPOTHYROIDISM AND RHABDOMYOLYSIS
    GOUTON, M
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1993, 86 (12): : 1761 - 1764
  • [28] New Era of Lipid-Lowering Drugs
    Barter, Philip J.
    Rye, Kerry-Anne
    PHARMACOLOGICAL REVIEWS, 2016, 68 (02) : 458 - 475
  • [29] COMBINATIONS OF DRUGS IN LIPID-LOWERING THERAPY
    LAROSA, JC
    AMERICAN JOURNAL OF MEDICINE, 1994, 96 (05): : 399 - 400
  • [30] New lipid-lowering drugs: an update
    Wierzbicki, A. S.
    Hardman, T. C.
    Viljoen, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 270 - 280
12345